US Stock MarketDetailed Quotes
THTX Theratechnologies
- 1.8300
- +0.0038+0.21%
Close Dec 26 16:00 ET
- 1.7800
- -0.0500-2.73%
Post 20:01 ET
84.14MMarket Cap-45.75P/E (TTM)
1.8900High1.7729Low52.89KVolume1.8900Open1.8262Pre Close97.55KTurnover0.15%Turnover RatioLossP/E (Static)45.98MShares2.580052wk High-4.28P/B62.67MFloat Cap1.080052wk Low--Dividend TTM34.24MShs Float17.8400Historical High--Div YieldTTM6.41%Amplitude0.8800Historical Low1.8440Avg Price1Lot Size
Theratechnologies Key Stats
Quarterly+Annual
YOY
| (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.37%22.6M | 25.46%22.02M | -18.39%16.25M | 2.13%81.76M | 9.48%23.45M | 0.21%20.86M | -8.92%17.55M | 7.28%19.91M | 14.66%80.06M | 14.22%21.42M |
| Operating revenue | 8.37%22.6M | 25.46%22.02M | -18.39%16.25M | 2.13%81.76M | 9.48%23.45M | 0.21%20.86M | -8.92%17.55M | 7.28%19.91M | 14.66%80.06M | 14.22%21.42M |
| Cost of revenue | -8.98%4.52M | -7.37%4.55M | 12.59%5.28M | -25.28%19.64M | -14.27%5.07M | -6.14%4.97M | -45.33%4.91M | -23.05%4.69M | 12.98%26.28M | -7.83%5.91M |
| Gross profit | 13.79%18.08M | 38.21%17.47M | -27.95%10.96M | 15.53%62.13M | 18.53%18.39M | 2.38%15.89M | 22.85%12.64M | 22.13%15.22M | 15.50%53.78M | 25.67%15.51M |
| Operating expense | -25.06%11.87M | -31.10%14.18M | -35.95%13.21M | -22.34%72.76M | -25.94%15.72M | -24.74%15.83M | -34.13%20.58M | 2.20%20.62M | 30.48%93.69M | 3.98%21.22M |
| Selling and administrative expenses | -11.34%9.25M | -7.24%9.46M | -16.06%9.46M | -25.31%42.39M | -10.86%10.49M | -17.24%10.44M | -49.51%10.2M | -7.47%11.27M | 30.38%56.75M | 0.30%11.77M |
| -Selling and marketing expense | -6.26%6.31M | -1.73%6.37M | -16.33%5.7M | -32.04%26.77M | -13.59%6.75M | -19.94%6.73M | -57.85%6.48M | -12.72%6.81M | 36.26%39.39M | -4.69%7.81M |
| -General and administrative expense | -20.57%2.95M | -16.85%3.09M | -15.63%3.76M | -10.02%15.62M | -5.49%3.74M | -11.86%3.71M | -22.95%3.72M | 1.92%4.45M | 18.75%17.36M | 11.85%3.96M |
| Research and development costs | -51.59%2.61M | -54.52%4.73M | -59.90%3.75M | -17.78%30.37M | -44.70%5.23M | -35.95%5.4M | -6.03%10.39M | 16.91%9.36M | 30.65%36.94M | 8.95%9.46M |
| Operating profit | 11,405.56%6.21M | 141.39%3.29M | 58.46%-2.25M | 73.37%-10.63M | 146.78%2.67M | 100.98%54K | 62.10%-7.94M | 29.96%-5.41M | -58.14%-39.91M | 29.23%-5.71M |
| Net non-operating interest income expense | 11.04%-2.3M | -3.03%-2.35M | -10.52%-2.33M | -70.33%-10.59M | -72.52%-3.62M | -73.52%-2.58M | -70.53%-2.28M | -62.93%-2.11M | -13.02%-6.22M | -56.30%-2.1M |
| Non-operating interest income | 122.89%370K | 63.64%342K | 85.02%420K | 143.35%769K | 15.97%167K | 130.56%166K | 287.04%209K | 393.48%227K | 62.05%316K | 176.92%144K |
| Non-operating interest expense | -3.02%2.66M | 8.54%2.7M | 14.29%2.65M | 59.47%10.36M | 25.65%2.82M | 76.01%2.74M | 80.32%2.48M | 75.66%2.32M | 14.71%6.5M | 62.35%2.24M |
| Total other finance cost | 50.00%6K | -166.67%-4K | 420.00%104K | 2,745.71%996K | 48,400.00%966K | 300.00%4K | -57.14%6K | -9.09%20K | 12.90%35K | -116.67%-2K |
| Other net income (expense) | -103.62%-69K | -50.74%166K | 107.31%207K | -246.42%-2.32M | -9,744.44%-1.74M | 587.98%1.91M | 209.77%337K | -28,400.00%-2.83M | 27.65%-670K | 103.78%18K |
| Gain on sale of security | -103.62%-69K | -50.74%166K | 168.77%207K | 263.88%1.1M | -4,800.00%-846K | 587.98%1.91M | 209.77%337K | -3,110.00%-301K | 27.65%-670K | 103.78%18K |
| Special income (charges) | ---- | ---- | --0 | ---3.42M | ---890K | ---- | ---- | ---2.53M | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --3.42M | --890K | ---- | ---- | --2.53M | ---- | ---- |
| Income before tax | 720.48%3.85M | 111.18%1.11M | 57.76%-4.37M | 49.70%-23.54M | 65.55%-2.68M | 91.62%-620K | 56.26%-9.89M | -14.90%-10.35M | -47.79%-46.79M | 21.21%-7.79M |
| Income tax | 500.00%756K | -6.35%118K | 14.58%110K | -4.97%421K | -48.95%73K | -16.56%126K | 3.28%126K | 255.56%96K | 603.17%443K | 652.63%143K |
| Net income | 514.34%3.09M | 109.86%987K | 57.09%-4.48M | 49.28%-23.96M | 65.25%-2.76M | 90.12%-746K | 55.94%-10.01M | -15.62%-10.44M | -48.90%-47.24M | 19.92%-7.93M |
| Net income continuous Operations | 514.34%3.09M | 109.86%987K | 57.09%-4.48M | 49.28%-23.96M | 65.25%-2.76M | 90.12%-746K | 55.94%-10.01M | -15.62%-10.44M | -48.90%-47.24M | 19.92%-7.93M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 514.34%3.09M | 109.86%987K | 57.09%-4.48M | 49.28%-23.96M | 65.25%-2.76M | 90.12%-746K | 55.94%-10.01M | -15.62%-10.44M | -48.90%-47.24M | 19.92%-7.93M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 514.34%3.09M | 109.86%987K | 57.09%-4.48M | 49.28%-23.96M | 65.25%-2.76M | 90.12%-746K | 55.94%-10.01M | -15.62%-10.44M | -48.90%-47.24M | 19.92%-7.93M |
| Basic earnings per share | 300.00%0.06 | 104.88%0.02 | 76.74%-0.1 | 54.04%-0.91 | 90.91%-0.03 | 90.63%-0.03 | 57.29%-0.41 | -19.44%-0.43 | -44.53%-1.98 | 19.51%-0.33 |
| Diluted earnings per share | 300.00%0.06 | 104.88%0.02 | 76.83%-0.1 | 54.04%-0.91 | 90.91%-0.03 | 90.63%-0.03 | 57.29%-0.41 | -19.86%-0.4315 | -44.53%-1.98 | 19.51%-0.33 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data